Byrna Technologies Inc. 8-K/A

What Happened Byrna Technologies Inc. filed an 8-K disclosing that President Luan Pham’s employment terminated without cause on June 13, 2026, and that the company and Mr. Pham entered into a Separation Agreement dated June 17, 2026. The agreement provides severance and benefits conditioned on Mr. Pham signing and not revoking a general release and complying with post‑employment covenants. The Separation Agreement includes cash payments, COBRA premium reimbursement, and accelerated vesting of certain restricted stock units (RSUs), subject to tax‑code timing rules.

Key Details

• Cash severance: 1.0× annual base salary — $380,000 gross, paid in substantially equal installments over 12 months; payments begin on the 61st day after the June 13, 2026 separation date.
• Pro‑rata bonus: lump‑sum short‑term incentive of $145,170 gross for the 2026 performance year, payable on the 61st day after separation.
• Health coverage: up to 12 months of COBRA premium reimbursement for Mr. Pham and eligible dependents, ending earlier if he gets similar employer coverage or loses COBRA eligibility.
• Equity treatment: accelerated full vesting of 20,810 RSUs granted March 17, 2026 (10,405 time‑based + 10,405 performance‑based); the VWAP performance condition on the performance RSUs was waived. Settlement of shares may be delayed up to six months post‑separation to comply with Section 409A. All other unvested equity awards were forfeited.

Why It Matters This filing confirms a leadership change and quantifies the near‑term cash and equity costs to Byrna: a $380K severance payment, a $145K pro‑rata bonus, potential COBRA reimbursements, and accelerated RSU vesting. The payments are contingent on Mr. Pham signing a release and abiding by restrictive covenants (non‑compete, non‑solicit, confidentiality, non‑disparagement), which reduces certain legal and competitive risks for the company. Investors should note the one‑time cash outflow and equity acceleration (possible dilution/timing of share issuance) but no forward‑looking guidance or other operational impacts were disclosed in this 8‑K.